All studies
AuthorisedTherapeutic exploratory (Phase II)Interventional

Paediatric sarcoma, hybrid imaging & FAPI – Raising the diagnostic standard for paediatric sarcoma patients combining novel radiotracer FAPI and whole-body PET/MRI

Sarcomas are rare cancers that develop in the bones or soft tissues, such as muscles. Doctors usually use scans to find where the cancer is and check how well treatments are working. This clinical trial is testing whether an advanced scanning technique called whole-body PET/MRI works better than standard scans. The trial uses a new tracer substance called FAPI, which is given through a small drip. This tracer attaches to specific proteins on tumour cells and glows gently on the scan, acting like a highlighter pen. Doctors will compare pictures taken with this new method against regular hospital scans. They want to see if the new scan finds tumours more accurately and whether it is easy and comfortable for young patients and their families to undergo.

At a glance

Status
Authorised
Phase
Therapeutic exploratory (Phase II)
Sponsor
Rigshospitalet
Enrolment target
40
Start
28 Aug 2026

What is this study about?

Sarcoma is a rare form of cancer that can develop in bones or soft tissues, such as muscles, fat, and nerves. When a child or young person has a sarcoma, having clear and detailed pictures of their body is essential. These pictures help doctors plan the best surgery or treatment and check whether the cancer has spread or returned.

At the moment, hospitals use standard scans like CT, MRI, or standard PET scans. While these are very helpful, doctors are always looking for clearer ways to spot tiny cancer cells. This study tests a cutting-edge approach combining two things: a whole-body PET/MRI scanner, which takes very sharp 3D pictures without using CT radiation, and a new imaging dye called FAPI. FAPI targets a specific protein found around sarcoma cells, helping them show up more clearly on screen.

The main goal of this research is to see if specialist doctors can spot cancer more accurately using this new scan compared to standard tests. Researchers also want to find out how young people and their parents feel about having the scan, and whether hospitals can easily introduce this new technology into everyday NHS care in the future.

Key takeaways

  • Tests a new scanning dye called FAPI combined with PET/MRI technology.
  • Aims to detect childhood sarcoma tumours more accurately than standard tests.
  • Does not replace your main cancer treatment, but adds an advanced scan.
  • Looks closely at how comfortable the scanning process is for young patients and parents.
  • Participation is entirely voluntary and you can change your mind at any point.

Who may be eligible?

This trial is designed for children and young people who have been diagnosed with sarcoma. Because sarcomas can affect people of different ages, the study is open to both male and female patients across paediatric age groups.

To be considered, patients must be able to have an MRI scan safely. For example, people with certain metal implants, like some pacemakers or clips, may not be able to take part. Your hospital care team will look closely at your overall health to ensure the scan is completely safe for you.

If you or your child are interested, your specialist cancer doctor can review the detailed medical criteria and confirm whether this study is an appropriate option alongside your regular care plan.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Diagnosed with a paediatric sarcoma (bone or soft tissue cancer)
  2. Able to safely have an MRI scan (no incompatible metal implants)
  3. Able to lie relatively still for imaging, with support if needed
  4. Willing to have a small injection of a specialised imaging tracer
  5. Supported by a parent or guardian if under 16 years of age
Answer every question to see your result.

What does participation involve?

Taking part in this study involves attending a hospital imaging department for specialised scans alongside your usual care. Before the scan, a small tube (cannula) will be placed into a vein to give the FAPI tracer dye. You will then rest quietly for a short period while the dye travels through the body.

Next, you will lie still inside a PET/MRI scanner while it takes detailed pictures. The scanner can be noisy, but you can wear headphones, and a parent or guardian can usually stay close by. The scanning appointment usually takes a few hours from start to finish. You may also be asked to fill in short questionnaires about how you felt during the scan. No changes are made to your regular cancer treatments, and no long-term extra hospital visits are usually needed beyond your scheduled scan days.

Potential risks and benefits

Taking part may not directly cure your condition, as this trial tests a diagnostic scan rather than a treatment. However, the new scan may provide your care team with clearer, more detailed pictures of the tumour. The main risks are minor and include brief discomfort or bruising from the needle used for the tracer injection. The scan uses a small, safe amount of radiation from the tracer, which specialists carefully control. Lying still in the scanner can feel boring or slightly enclosed, but the team will keep you comfortable. Taking part is completely voluntary, and you can stop at any time without it affecting your standard NHS care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Denmark

Common questions

What is a PET/MRI scan?

It is an advanced machine that combines two scans in one: an MRI, which takes sharp pictures of soft tissues, and a PET scan, which highlights active cells using a safe tracer dye.

Does the scan hurt?

No, the scan itself is completely painless. The only mild discomfort is the quick pinch of a needle when the tracer dye is given through a drip.

Can parents stay in the room during the scan?

Yes, in most cases a parent or carer can remain in the scanning room to provide reassurance, as long as it is safe for them to enter the MRI area.

Will taking part delay normal cancer treatment?

No, the study scan is planned carefully alongside standard treatment so that your regular medical care continues without unnecessary delays.

Is the radioactive tracer dangerous?

The tracer uses a very low, carefully calculated dose of radiation that leaves the body quickly. Doctors consider it very safe for diagnostic use.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.